MediPharm Labs (MEDIF) Stock Chart & Stock Price History $0.06 +0.00 (+7.58%) As of 03:39 PM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesShort InterestBuy This Stock MediPharm Labs Stock Price Performance The MediPharm Labs (MEDIF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 2.35%, with a year-to-date return of 40.92%. In the past month, the stock has decreased 8.35%, reflecting recent market activity. As of the latest close, MediPharm Labs traded at $0.05 with a market cap of and volume of 163,307 shares. Five years ago, the stock traded at $1.40, representing a 95.83% decrease over that period. At the time, it had a market cap of and a volume of 223,887 shares. Receive MEDIF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.19%1 Month Performance-8.35%3 Month Performance+21.25%Year-To-Date Performance+40.92%1 Year Performance-2.35%5 Year Performance-95.83% MEDIF Stock Chart for Friday, May, 30, 2025 MEDIF Chart by TradingView MediPharm Labs Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/30/2025$0.05$0.06+7.58%$0.06$0.05642,381 shs$0.0005/29/2025$0.06$0.05-5.75%$0.06$0.05163,307 shs$0.0005/28/2025$0.06$0.06+4.36%$0.06$0.06103,817 shs$0.0005/27/2025$0.06$0.06-6.62%$0.06$0.05231,401 shs$0.0005/26/2025$0.06$0.06$0.06$0.05106,292 shs$0.0005/23/2025$0.06$0.06+2.79%$0.06$0.05106,292 shs$0.0005/22/2025$0.05$0.06+5.14%$0.06$0.0577,471 shs$0.0005/21/2025$0.06$0.05-12.10%$0.06$0.05307,047 shs$0.0005/20/2025$0.07$0.06-8.82%$0.07$0.0652,908 shs$0.0005/19/2025$0.06$0.07+4.94%$0.07$0.0529,973 shs$0.00 Get the Latest News and Ratings for MEDIF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter. 05/16/2025$0.07$0.06-7.43%$0.07$0.06627,347 shs$0.0005/15/2025$0.08$0.07-7.16%$0.08$0.0677,012 shs$0.0005/14/2025$0.07$0.08+7.71%$0.08$0.07120,308 shs$0.0005/13/2025$0.06$0.07+10.06%$0.07$0.06174,265 shs$0.0005/12/2025$0.07$0.06-3.64%$0.06$0.064,016 shs$0.0005/09/2025$0.06$0.07+1.69%$0.07$0.0688,185 shs$0.0005/08/2025$0.07$0.06-1.22%$0.07$0.0681,987 shs$0.0005/07/2025$0.06$0.07+4.29%$0.07$0.0622,679 shs$0.0005/06/2025$0.06$0.06-2.48%$0.07$0.0611,699 shs$0.0005/05/2025$0.07$0.06-1.52%$0.07$0.0621,751 shs$0.0005/02/2025$0.06$0.07+7.36%$0.07$0.0620,102 shs$0.0005/01/2025$0.06$0.06-3.78%$0.07$0.0529,274 shs$0.0004/30/2025$0.06$0.06+4.10%$0.07$0.0671,384 shs$0.0004/29/2025$0.06$0.06+8.16%$0.07$0.06368,383 shs$0.00 Related Companies TGIFF Stock Price Chart CATV Stock Price Chart FFNTF Stock Price Chart ABSCF Stock Price Chart ATTBF Stock Price Chart ACRHF Stock Price Chart ACRDF Stock Price Chart ALEAF Stock Price Chart LBTSF Stock Price Chart ALVOW Stock Price Chart Receive MEDIF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:MEDIF) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediPharm Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
